Home
>
National Drug Code (NDC)
>
Cardiolite
Cardiolite - 11994-001-00 - (TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE)
Drug Information of Cardiolite
| Product NDC: | 11994-001 |
| Proprietary Name: | Cardiolite |
| Non Proprietary Name: | TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE |
| Active Ingredient(s): | 1 mg/mL & nbsp; TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cardiolite
| Product NDC: | 11994-001 |
| Labeler Name: | Lantheus Medical Imaging, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019785 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19901220 |
Package Information of Cardiolite
| Package NDC: | 11994-001-00 |
| Package Description: | 5 mL in 1 SYRINGE (11994-001-00) |
NDC Information of Cardiolite
| NDC Code | 11994-001-00 |
| Proprietary Name | Cardiolite |
| Package Description | 5 mL in 1 SYRINGE (11994-001-00) |
| Product NDC | 11994-001 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19901220 |
| Marketing Category Name | NDA |
| Labeler Name | Lantheus Medical Imaging, Inc. |
| Substance Name | TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
